Nitroxyl (HNO) signaling

Free Radical Biology and Medicine

Volumn 47, Issue 9, 2009, Pages 1318-1324

  Fukuto, Jon M ^a   Bianco, Christopher L ^a   Chavez, Tyler A ^a  

^a SONOMA STATE UNIVERSITY   (United States)

Author keywords

cGMP; CGRP; Inotropy; Metal complexes; Nitric oxide; Nitroxyl; Soluble guanylate cyclase; Thiol oxidation; Vasodilation

Indexed keywords

ALDEHYDE DEHYDROGENASE; CALCITONIN GENE RELATED PEPTIDE; CALCIUM ION; CYCLIC GMP; ENDOTHELIUM DERIVED RELAXING FACTOR; GLUTATHIONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE; NITROGEN OXIDE; NITROXYL; RYANODINE RECEPTOR; RYANODINE RECEPTOR 2; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

CALCIUM SIGNALING; CARDIOVASCULAR DISEASE; DRUG POTENCY; DRUG TARGETING; ENZYME INHIBITION; GLYCOLYSIS; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; VASODILATATION; YEAST;

ANIMALS; HUMANS; NITROGEN OXIDES; SIGNAL TRANSDUCTION;

EID: 70349814248     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.06.014     Document Type: Review

References (75)

1. Murad F. Nitric oxide and cyclic GMP in cell signaling and drug development. N. Engl. J. Med. 355 (2006) 2003-2011
2. Mason M.G., Nicholls P., Wilson M.T., and Cooper C.E. Nitric oxide inhibition of respiration involves both competitive (heme) and noncompetitive (copper) binding to cytochrome c oxidase. Proc. Natl. Acad. Sci. USA 103 (2006) 708-713
3. Brune B., and Zhou J. Nitric oxide and superoxide: interference with hypoxic signaling. Cardiovasc. Res. 75 (2007) 275-282
4. Espey MG., Miranda K.M., Thomas D.D., Xavier S., Citrin D., Vitek M.P., and Wink D.A.A. chemical perspective on the interplay between NO, reactive oxygen species and reactive nitrogen species. Ann. N. Y. Acad. Sci. 962 (2002) 195-206
5. Fukuto J.M., Bartberger M.D., Dutton A.S., Paolocci N., Wink D.A., and Houk K.N. The physiological chemistry and biological activity of nitroxyl (HNO): the neglected, misunderstood and enigmatic nitrogen oxide. Chem. Res. Toxicol. 18 (2005) 790-801
6. Paolocci N., Jackson M.I., Lopez B.E., Miranda K., Tochetti C.G., Wink D.A., Hobbs A.J., and Fukuto J.M. The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the janus face of NO. Pharmacol. Ther. 113 (2007) 442-458
7. Irvine J.C., Ritchie R.H., Favaloro J.L., Andrews K.L., Widdop R.E., and Kemp-Harper B.K. Nitroxyl (HNO): the Cinderella of the nitric oxide story. Trends Pharmacol. Sci. 29 (2008) 601-608
8. DeMaster E.G., Kaplan E., Shirota F.N., and Nagasawa H.T. Metabolic activation of cyanamide by liver mitochondria, a requirement for the inhibition of aldehyde dehydrogenase enzymes. Biochem. Biophys. Res. Commun. 107 (1982) 1333-1339
9. DeMaster E.G., Nagasawa H.T., and Shirota F.N. Metabolic activation of cyanamide to an inhibitor of aldehyde dehydrogenase in vitro. Pharmacol. Biochem. Behav. 18 (1983) 273-277
10. DeMaster E.G., Shirota F.N., and Nagasawa H.T. The metabolic activation of cyanamide to an inhibitor of aldehyde dehydrogenase is catalyzed by catalase. Biochem. Biophys. Res. Commun. 122 (1984) 358-365
11. DeMaster E.G., Shirota F.N., and Nagasawa H.T. Catalase mediated conversion of cyanamide to an inhibitor of aldehyde dehydrogenase. Alcohol 2 (1985) 117-121
12. DeMaster E.G., redfern B., and Nagasawa H.T. Mechanisms of inhibition of aldehyde dehydrogenase by nitroxyl, the active metabolite of the alcohol deterrent agent cyanamide. Biochem. Pharmacol. 55 (1998) 2007-2015
13. Nagasawa H.T., DeMaster E.G., Redfern B., Shirota F.N., and Goon D.J.W. Evidence for nitroxyl in the catalase-mediated bioactivation of the alcohol deterrent agent cyanamide. J. Med. Chem. 33 (1990) 3120-3122
14. Nagasawa H.T., Lee M.J.C., Kwon C.H., Shirota F.N., and DeMaster E.G. An N-hydroxylated derivative of cyanamide that inhibits yeast aldehyde dehydrogenase. Alcohol 9 (1992) 349-353
15. Lopez B.E., Rodriguez C.E., Pribadi M., Cook N., Shinyashiki M., and Fukuto J.M. Selective inhibition of yeast glycolysis by nitroxyl (HNO): implications to HNO pharmacology/physiology. Arch. Biochem. Biophys. 442 (2005) 140-148
16. Lopez B.E., Wink D.A., and Fukuto J.M. The inhibition of glyceraldehyde-3-phosphate dehydrogenase by nitroxyl (HNO). Arch. Biochem. Biophys. 465 (2007) 430-436
17. Shen B., and English A.M. Mass spectrometric analysis of nitroxyl-mediated protein modification: comparison of products formed with free and protein-based cysteines. Biochemistry 44 (2005) 14030-14044
18. Vaananen A.J., Kankuri E., and Rauhala P. Nitric oxide-related species-induced protein oxidation: reversible, irreversible and protective effects on enzyme function of papain. Free Radic. Biol. Med. 38 (2005) 1102-1111
19. Vaananen A.J., Salmenpera P., Hukkanen M., Rauhala P., and Kankuri E. Cathepsin B is a differentiation-resistant target for nitroxyl (HNO) in THP-1 monocyte/macrophages. Free Radic. Biol. Med. 41 (2006) 120-131
20. Vaananen A.J., Salmenpera P., Hukkanen M., Miranda K.M., Harjula A., Rauhala P., and Kankuri E. Persistent susceptibility of cathepsin B to irreversible inhibition of nitroxyl (HNO) in the presence of endogenous nitric oxide. Free Radic. Biol. Med. 45 (2008) 744-749
21. Paolocci N., Saavedra W.F., Miranda K.M., Martignani C., Isoda T., Hare J.M., Espey M.G., Fukuto J.M., Feelisch M., Wink D.A., and Kass D.A. Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc. Natl. Acad. Sci. USA 98 (2001) 10463-10468
22. Paolocci N., Katori T., Champion H.C., St. John M.E., Miranda K.M., Fukuto J.M., Wink D.A., and Kass D.A. Positive inotropic and lusitropic effects of HNO/NO- in failing hearts: independence from β-adrenergic signaling. Proc. Natl. Acad. Sci. USA 100 (2003) 5537-5542
23. Tocchetti C.G., Wang W., Froehlich J.P., Huke S., Aon M.A., Wilson G.M., DiBenedetto G., O'Rourke B., Gao W.D., Wink D.A., Toscano J.P., Zaccolo M., Bers D.M., Valdivia H.H., Cheng H., Kass D.A., and Paolocci N. Nitroxyl improves cellular heart finction by directly enhancing cardiac sarcoplasmic reticulum Ca2+ cycling. Circ. Res. 100 (2007) 96-104
24. Dai T., Tian Y., Tochetti G., Katori T., Murphy A.M., Kass D.A., Paolocci N., and Gao W.D. Nitroxyl increases force development in rat cardiac muscle. J. Physiol. 580 (2007) 951-960
25. Feelisch M. Nitroxyl gets to the heart of the matter. Proc. Natl. Acad. Sci. USA 100 (2003) 4978-4980
26. Hildago C., Donoso P., and Carrasco M.A. The ryanodine receptors Ca2+ release channels: cellular redox sensors. IUBMB Life 57 (2005) 315-322
27. Cheong E., Tumbev V., Abramson J., Salama G., and Stoyanovsky D.A. Nitroxyl triggers Ca2+ release from skeletal and cardiac sarcoplasmic reticulum by oxidizing ryanodine receptors. Cell Calcium 37 (2005) 87-96
28. Froehlich J.P., Mahaney J.E., Keceli G., Pavlos C.M., Goldstein R., Redwood A.J., Sumbilla C., Lee D.I., Tocchetti C.G., Kass D.A., Paolocci N., and Toscano J.P. Phospholamban thiols play a central role in activation of the cardiac muscle sarcoplasmic reticulum calcium pump by nitroxyl. Biochemistry 47 (2008) 13150-13152
29. Lancel S., Zhang J., Evangelista A., Trucillo M.P., Tong X.Y., Siwik D.A., Cohen R.A., and Colucci W.S. Nitroxyl activates SERCA in cardiac myocytes via glutathionylation of cysteine 674. Circ. Res. 104 (2009) 720-723
30. Furchgott R.F., and Zawadzki J. V The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
31. Fukuto J.M., Chiang K., Hszieh R., Wong P., and Chaudhuri G. The pharmacological properties of nitroxyl (HNO): a potent vasodilator with activity similar to nitric oxide (NO) and/or endothelium-derived relaxing factor (EDRF). J. Pharmacol. Exp. Ther. 263 (1992) 546-551
32. Murphy M.E., and Sies H. Reversible conversion of nitroxyl anion to nitric oxide by superoxide dismutase. Proc. Natl. Acad. Sci. USA 88 (1991) 10860-10864
33. Fukuto J.M., Hobbs A.J., and Ignarro L.J. Conversion of nitroxyl (HNO) to nitric oxide in biological systems: the role of physiological oxidants and relevance to the biological activity of HNO. Biochem. Biophys. Res. Commun. 196 (1993) 707-713
34. Ellis A., Li C.G., and Rand M.J. Differeential actions of L-cysteine on responses to nitric oxide, nitroxyl anions and EDRF in rat aorta. Br. J. Pharmacol. 129 (2000) 315-322
35. Pino R.Z., and Feelisch M. Bioassay discrimination between nitric oxide (NO·) and nitroxyl (NO-) using L-cysteine. Biochem. Biophys. Res. Commun. 201 (1994) 54-62
36. Wanstall J.C., Jeffery T.K., Gambino A., Lovren F., and Triggle C.R. Vascular smooth muscle relaxation mediated by nitric oxide donors: a comparison with acetylcholine, nitric oxide and nitroxyl ion. Br. J. Pharmacol. 134 (2001) 463-472
37. Irvine J.C., Favaloro J.L., and Kemp-Harper B.K. NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries. Hypertension 41 (2003) 1301-1307
38. Favaloro J.L., and Kemp-Harper B.K. The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature. Cardiovasc. Res. 73 (2007) 587-596
39. Dierks E., and Burstyn J. Nitric oxide, the only nitrogen monoxide redox form capable of activating soluble guanylate cyclase. Biochem. Pharmacol. 51 (1996) 1593-1600
40. Costa G., Labadia A., Triguero D., Jimenez E., and Garcia-Pascual A. Nitrergic relaxation in urethral smooth muscle: involvement of potassium channels and alternative redox forms of NO. Naunyn-Schmiedebergs Arch. Pharmacol. 364 (2001) 516-523
41. Favaloro J.L., and Kemp-Harper B.K. Redox variants of nitric oxide (NO and HNO) elicit vasorelaxation of reistance arteries via distinct mechanisms. Am. J. Physiol. Heart Circ. Physiol. 296 (2009) H1274-H1280
42. Andrews K.L., Irvine J.C., Tare M., Apostolopoulos J., Favaloro J.L., Triggle C.R., and Kemp-Harper B.K. A role for nitroxyl (HNO) as an endothelium-derived relaxing and hyperpolarizing factor in resistance arteries. Br. J. Pharmacol. 157 (2009) 540-550
43. Katori T., Hoover D.B., Ardell J.L., Helm R.H., Belardi D.F., Tocchetti C.G., Forfia P.R., Kass D.A., and Paolocci N. Calcitonin gene-related peptide in vivo positive inotropy is attributable to regional sympatho-stimulation and is blunted in congestive heart failure. Circ. Res. 96 (2005) 234-243
44. Pagliaro P., Mancardi D., Rastaldo R., Penna C., Gattullo D., Miranda K.M., Feelisch M., Wink D.A., Kass D.A., and Paolooci N. Nitroxyl affords thiol-sensitive myocardial protective effects akin to early preconditioning. Free Radic. Biol. Med. 34 (2003) 33-43
45. Ma X.L., Gao F., Liu G.L., Lopez B.L., Christopher T.A., Fukuto J.M., Wink D.A., and Feelisch M. Opposite effects of nitric oxide and nitroxyl on postischemic myocardial injury. Proc. Natl. Acad. Sci., USA 96 (1999) 14617-14622
46. Shiva S.C.J., Ramachandran A., Ceaser E.K., Hillson T., Brookes P.S., Patel R.P., and Darley-Usmar V.M. Mechanisms of the interaction of nitroxyl with mitochondria. Biochem. J. 379 (2004) 359-366
47. Naughton P., Foresti R., Bains S.K., Hoque M., Green C.J., and Motterlini R. Induction of heme oxygenase 1 by nitrosative stress, a role for nitroxyl anion. J. Biol. Chem. 277 (2002) 40666-40674
48. Wink D.A., Feelisch M., Fukuto J., Christodoulou D., Jourd'heuil D., Grisham M., Vodovotz V., Cook J.A., Krishna M., DeGraff W., Kim S., Gamson J., and Mitchell J.B. The cytotoxicity of nitroxyl: possible implications for the pathophysiological role of NO. Arch. Biochem. Biophys. 351 (1998) 66-74
49. Lopez B.E., Han T.H., Shinyashiki M., and Fukuto J.M. The antioxidant actions of nitroxyl (HNO). Free Radic. Biol. Med. 42 (2007) 482-491
50. Katori T., Donzelli S., Tocchetti C.G., Miranda K.M., Cormaci G., Thomas D.D., Ketner E.A., Lee M.J., Mancardi D., Wink D.A., Kass D.A., and Paolocci N. Peroxynitrite and myocardial contractility: in vivo versus in vitro effects. Free Radic. Biol. Med. 41 (2006) 1606-1618
51. Kim W.K., Choi Y.B., Rayudu P.V., Das P., Asaad W., Arnelle D.R., Stamler J.S., and Lipton S.A. Attenuation of NMDA receptor activity and neurotoxicity by nitroxyl anion, NO-. Neuron 24 (1999) 461-469
52. Colton C.A., Gbadegesin M., Wink D.A., Miranda K.M., Espey M.G., and Vicini S. Nitroxyl anion regulation of the NMDA receptor. J. Neurochem. 78 (2001) 1126-1134
53. Miranda K.M. The chemistry of nitroxyl (HNO) and implications in biology. Coord. Chem. Rev. 249 (2005) 433-455
54. Gratzel M., Taniguchi S., and Henglein A. A pulse radiolytic study of short-lived byproducts on nitric oxide reduction in aqueous solution. Ber. Bunsenges. Phys. Chem. 74 (1970) 1003-1010
55. Shafirovich V., and Lymar S.V. Nitroxyl and its anion in aqueous solutions: Spin states, protic equilibria, and reactivities toward oxygen and nitric oxide. Proc. Natl. Acad. Sci. USA 99 (2002) 7340-7345
56. Bartberger M.D., Fukuto J.M., and Houk K.N. On the acidity and reactivity of HNO in aqueous solution and biological systems. Proc. Natl. Acad. Sci. USA 98 (2001) 2194-2198
57. Bartberger M.D., Liu W., Ford E., Miranda K.M., Switzer C., Fukuto J.M., Farmer P.J., Wink D.A., and Houk K.N. The reduction potential of nitric oxide (NO) and its importance to NO biochemistry. Proc. Natl. Acad. Sci. USA 99 (2002) 10958-10963
58. Miranda K.M., Paolocci N., Katori T., Thomas D.D., Ford E., Bartberger M.D., Espey M.G., Kass D.A., Fukuto J.M., and Wink D.A. A biochemical rationale for the discrete behavior of nitroxyl and nitric oxide in the cardiovascular system. Proc. Natl. Acad. Sci. USA 100 (2003) 9197-9201
59. Doyle M.P., Mahapatro S.N., Broene R.D., and Guy J.K. Oxidation and reduction of hemoproteins by trioxodinitrate(II). The role of nitrosyl hydride and nitrite. J. Am. Chem. Soc. 110 (1988) 593-599
60. Wong P.S.Y., Hyun J., Fukuto J.M., Shirota F.N., DeMaster E.G., Shoeman D.W., and Nagasawa H.T. Reaction between S-nitrosothiols and thiols: generation of nitroxyl (HNO) and subsequent chemistry. Biochemistry 37 (1998) 5362-5371
61. Shen B., and English A.M. Mass spectrometric analysis of nitroxyl-mediated protein modification: comparison of products formed with free and protein-based cysteines. Biochemistry 44 (2005) 14030-14044
62. Jacob C., Giles G.I., Giles N.M., and Sies H. Sulfur and selenium: The role of oxidation state in protein structure and function. Angew. Chem. Int. Ed. 42 (2003) 4742-4758
63. Woo H.A., Chae H.Z., Hwang S.C., Yang K.-S., Kang S.W., Kim K., and Rhee S.G. Reversing the inactivation of peroxiredoxins caused y cysteine sulfinic acid formation. Science 300 (2003) 653-656
64. Woo H.A., Jeong W., Chang T.-S., Park K.J., Park S.J., Yang J.S., and Rhee S.G. Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J. Biol. Chem. 280 (2005) 3125-3128
65. Farmer P.J., and Sulc F. Coordination chemistry of the HNO ligand with hemes and synthetic coordination complexes. J. Inorg. Biochem. 99 (2005) 166-184
66. Sulc F., Fleischer E., Farmer P.J., Ma D., and LaMar G.N. 1H-NMR structure of the heme pocket of HNO-myoglobin. J. Biol. Inorg. Chem. 8 (2003) 348-352
67. Sulc F., Immoos C.E., Pervitsky D., and Farmer P.J. Efficient trapping of HNO by deoxymyoglobin. J. Am. Chem. Soc. 126 (2004) 1096-1101
68. Immoos C.E., Sulc F., Farmer P.J., Czarnecki K., Bocian D.F., Levina A., Aitken J.B., Armstrong R.S., and Lay P.A. Bonding in HNO-myoglobin as characterized by X-ray absorption and resonance Raman spectroscopies. J. Am. Chem. Soc. 127 (2005) 814-815
69. Linder D.P., and Rodgers K.R. Structural, electronic and vibrational characterization of Fe-HNO porphyrinatesby density functional theory. Inorg. Chem. 44 (2005) 8259-8264
70. Traylor T.G., and Sharma V.S. Why NO?. Biochemistry 31 (1992) 2847-2849
71. Dixon R.N. The heats of formation of HNO and DNO. J. Chem. Phys. 104 (1996) 6905-6906
72. Rubo H., Radi R., Trujillo M., Telleri R., Kalyanaraman B., Barnes S., Kirk M., and Freeman B.A. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. J. Biol. Chem. 269 (1994) 26066-26075
73. Miranda K.M., Espey M.G., Yamada K., Krishna M., Ludwick N., Kim S., Jourd'heuil D., Grisham M.B., Feelisch M., Fukuto J.M., and Wink D.A. Unique oxidative mechanisms for the reactive nitrogen oxide species, nitroxyl anion. J. Biol. Chem. 276 (2001) 1720-1727
74. Paolocci N., and Wink D.A. The shy Angeli and his elusive creature: the HNO route to vasodilation. Am. J. Physiol. Heart Circ. Physiol. 296 (2009) H1217-H1220
75. Donzelli S., Espey M.G., Thomas D.D., Mancardi D., Tocchetti C.G., Ridnour L.A., Paolocci N., King S.B., Miranda K.M., Lazzarino G., Fukuto J.M., and Wink D.A. Discriminating formation of HNO from other reactive nitrogen oxide species. Free Radic. Biol. Med. 40 (2006) 1056-1066